Depo-Provera Lawsuit Settlement | February 2026 Litigation Update

This piece is structured as a time-stamped litigation update focused on February 2026 developments—court rulings, filings, and settlement chatter—so readers can see where Depo-Provera cases stand now, not just in theory.

Litigation over Depo-Provera (medroxyprogesterone acetate) and its alleged link to meningiomas continues to move through the courts. This post summarizes settlement and litigation developments as of February 2026—and where things may go from here. For background on the drug and the science, see our article on Depo-Provera and brain tumors.

Current Status of Litigation (February 2026)

As of February 2026, Depo-Provera meningioma litigation remains active. Cases allege that long-term use of the injectable contraceptive increased the risk of meningioma—a type of brain tumor—and that manufacturers did not adequately warn patients and prescribers. Plaintiffs are seeking compensation for medical costs, lost wages, pain and suffering, and related harms.

Case filings have continued in state and federal courts. Some matters have been consolidated or coordinated for pretrial proceedings to streamline discovery and rulings on common issues. No global settlement program has been announced as of this update; any future settlement would be subject to court approval and eligibility criteria. Litigation timelines vary by court and case.

Settlement Developments and What to Expect

Settlement activity in mass torts often follows bellwether trials or court rulings on key legal and scientific issues. In Depo-Provera litigation, the path to potential settlements depends on how courts handle motions, expert evidence, and any early trial outcomes. Settlement discussions, when they occur, are typically confidential.

Desk with documents and papers for litigation update

If settlement programs are established in the future, they may set criteria such as duration of Depo-Provera use, diagnosis of meningioma, and documentation requirements. Compensation would be determined under the terms of any such program—not guaranteed in amount or timing. Staying informed through your legal team or a Depo-Provera lawsuit information resource can help you understand when and how to participate if you qualify.

According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.

The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.

See if you qualify for a free case review to learn whether your situation may fit current or future litigation or settlement options.

Who May Be Affected

Women who used Depo-Provera for an extended period and were later diagnosed with a meningioma may be affected by this litigation. Research has suggested higher risk with longer use (e.g., several years or more). Eligibility for any claim or future settlement will depend on the specific rules set by courts or settlement programs, plus your medical and use history. You can read more about Depo-Provera lawsuit eligibility to see common factors that are considered.

What a Case Review Involves

A case review is a free, confidential evaluation to see whether you may qualify to pursue a claim or be considered for a future settlement. It typically involves discussing your Depo-Provera use (how long, when), your meningioma diagnosis and treatment, and relevant records. There is no obligation to file a case, and many attorneys work on a contingency basis—fees only if there is a recovery. If you qualify, you may be connected with an independent law firm that handles these cases.

Important Disclaimers

This update is for informational purposes only and does not constitute legal advice. Litigation and settlement news changes over time; status and outcomes are not guaranteed. Statutes of limitations apply and vary by state—missing a deadline can bar a claim. Top Tier Legal, LLC is not a law firm and does not provide legal advice or representation. If you qualify, we may connect you with an independent law firm. Past results do not guarantee future outcomes.

The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.

According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.

The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.

A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.

According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.

If you used Depo-Provera long-term and have been diagnosed with a meningioma, consider having your situation evaluated. You can contact us for a free case review to see whether you may qualify.

According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.

Frequently asked questions (Quick reference)

Q: What does this guide cover regarding Depo-Provera Lawsuit Settlement?

It summarizes commonly asked questions about Depo-Provera Lawsuit Settlement in the "Drug Safety" area. Specific facts can change outcomes, so treat it as background reading before speaking with qualified counsel.

Q: Is reading this page the same as getting legal advice?

No. Top Tier Legal, LLC is not a law firm. Nothing here forms an attorney–client relationship. If you qualify, Top Tier Legal, LLC may connect you with an independent law firm.

Q: How can I request a free case review related to Depo-Provera Lawsuit Settlement?

Visit the site's contact options and explain your facts. Representatives can route you toward a complimentary review if appropriate; there is no guarantee of qualification.

Q: What role does Top Tier Legal play when I submit information?

Top Tier Legal focuses on informational resources and introductions. Approved submissions may be introduced to contingent-fee litigation teams for independent vetting.

Q: Could time limits affect a potential claim tied to Depo-Provera Lawsuit Settlement?

Yes. Missing a statutory deadline usually bars recovery. Because rules vary widely, promptly confirm your timeline with lawyers handling Depo-Provera Lawsuit Settlement-related consultations.

Top Tier Legal, LLC is not a law firm and does not provide legal advice. This content is for informational purposes only. Submitting information does not create an attorney-client relationship. If you qualify, Top Tier Legal, LLC may connect you with an independent law firm. Past results do not guarantee future outcomes.